Acya B.
- Country
- France
- Department
- Pneumology
Research Overview
- Phase III Randomized Controlled Trial of Pembrolizumab with Platinum-Based Chemotherapy Versus Pembrolizumab Monotherapy in First-Line Treatment of NSCLC with PD-L1 ≥50%
- IFCT-2201 ADAPTABLE A non-comparative randomized phase II trial evaluating the combination of paclitaxel-bevacizumab ± atezolizumab in patients with advanced non-squamous NSCLC progressing after immunotherapy and chemotherapy
- Comparison of Sotorasib Plus Combination Therapy Versus Pembrolizumab Plus Combination Therapy in PD-L1 Negative KRAS p.G12C Positive Advanced Non-Squamous NSCLC
Data & Insights
Has run more than one trial at 80 of 274 partner sites.
Specializations
Respiratory Medicine and Pulmonary Disorders
The investigator's clinical practice centers on the comprehensive management of respiratory diseases, with particular emphasis on advanced diagnostic and therapeutic approaches in pneumology. Working within a specialized respiratory medicine unit, the focus encompasses a broad spectrum of pulmonary conditions requiring both acute and long-term management strategies.
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma and Airway Inflammation
- Interstitial Lung Diseases
- Pulmonary Function Assessment
The investigator's involvement in clinical research reflects a commitment to advancing evidence-based treatments for patients with complex respiratory pathologies, contributing to the development of novel therapeutic interventions that address unmet medical needs in pulmonary care.
Hospital-Based Clinical Investigation
Operating within a regional hospital setting, the investigator participates in multicenter clinical trials that evaluate emerging treatments and diagnostic modalities. This work involves collaboration across multiple healthcare institutions to assess the safety and efficacy of new medical interventions in real-world clinical environments.
- Regional Healthcare Coordination
- Patient Recruitment and Monitoring
- Clinical Protocol Implementation
The investigator's position facilitates access to diverse patient populations, enabling participation in studies that require robust data collection and adherence to rigorous clinical trial standards within the framework of hospital-based research.
Therapeutic Innovation in Lung Disease Management
The clinical research portfolio demonstrates active engagement with pharmacological interventions designed to improve outcomes for patients with debilitating respiratory conditions. This includes participation in trials exploring novel mechanisms of action and treatment paradigms that may offer alternatives to conventional therapies.
- Bronchodilator Therapies
- Anti-inflammatory Agents
- Biological Therapies for Respiratory Diseases
Through systematic evaluation of new therapeutic options, the investigator contributes to the expanding knowledge base regarding optimal management strategies for patients with chronic respiratory insufficiency and related complications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.